DEF: Conduit Pharmaceuticals Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

Conduit Pharmaceuticals is asking stockholders to approve a reverse stock split, ranging from 1-for-2 to 1-for-100 (and up to 1-for-250 in aggregate), to potentially maintain its Nasdaq listing and attract investors.

Summary

• Conduit Pharmaceuticals is seeking stockholder approval for one or more amendments to its Second Amended and Restated Certificate of Incorporation to effect a reverse stock split.
• The proposed reverse stock split would consolidate shares of common stock at a ratio ranging from 1-for-2 to 1-for-100, with an aggregate limit of 1-for-250.
• The board of directors will determine the exact ratio and timing of the reverse stock split based on market conditions and the company's stock price.
• The primary purpose of the reverse stock split is to maintain compliance with Nasdaq's minimum bid price requirement and potentially increase investor interest.
• The reverse stock split will not change the number of authorized shares of common stock or the par value of the stock.
• Stockholders will receive cash in lieu of fractional shares resulting from the reverse stock split.
• The board has the authority to abandon the reverse stock split if it determines it is no longer in the best interests of the company.
• As of April 21, 2025, Conduit Pharmaceuticals had 11,338,523 shares of common stock outstanding.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting the reverse stock split as a necessary measure to maintain Nasdaq listing and potentially improve investor interest. While there are potential benefits, the document also acknowledges the risks and uncertainties associated with the reverse stock split.

Positives

• The reverse stock split could help Conduit Pharmaceuticals maintain its listing on the Nasdaq Global Market.
• A higher stock price resulting from the reverse stock split may attract more investors and brokerage firms.
• Increased investor interest could lead to higher trading volume and facilitate future financings.
• A higher stock price may help the company attract and retain employees.

Negatives

• There is no guarantee that the reverse stock split will increase the per share price of the common stock.
• The market price of the common stock will still depend on the company's performance and other factors.
• If the stock price declines after the reverse stock split, the percentage decline may be greater.
• The liquidity of the common stock could be adversely affected by the reduced number of outstanding shares.

Risks

• The reverse stock split may not result in a sustained increase in the stock price.
• The company may still fail to meet Nasdaq's minimum bid price requirement even after the reverse stock split.
• Reduced liquidity of the common stock could negatively impact investors.
• The market price of the common stock will still be based on the performance of the company, and other factors, some of which are unrelated to the number of shares outstanding.

Future Outlook

The company will monitor the closing bid price of its Common Stock and if it believes that any Reverse Stock Split is its best option for continuing compliance with the Minimum Bid Price Requirement, then it will undertake such Reverse Stock Split at a ratio to be determined by the Board in accordance with Proposal 1.

Management Comments

• The Board believes that stockholder approval of one or more Amendments to effect a Reverse Stock Split in a range of ratios (as opposed to a single Reverse Stock Split Ratio) and to authorize one or more Amendments is in the best interests of the Company and stockholders because it is not possible to predict market conditions at the time that any Reverse Stock Split would be effected.
• We believe that a range of Reverse Stock Split Ratios provides us with the most flexibility to achieve the desired results of any Reverse Stock Split through one or more Amendments.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low stock prices. They are often used to regain compliance with minimum bid price requirements and improve the stock's appeal to institutional investors.

Comparison to Industry Standards

• Many companies facing similar situations, such as delisting warnings from Nasdaq or NYSE, have implemented reverse stock splits.
• For example, companies like Ocugen, Inc. and CytoDyn Inc. have recently undergone reverse stock splits to maintain their Nasdaq listings.
• The success of a reverse stock split in increasing and sustaining the stock price varies widely and depends on the company's underlying fundamentals and market conditions.

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, as their shares will be consolidated.
• The reverse stock split could affect the market price and liquidity of the company's stock.
• Employees may benefit from a higher stock price, which could improve the company's ability to attract and retain talent.

Next Steps

• Stockholders will vote on the proposed reverse stock split at the Special Meeting on May 5, 2025.
• If approved, the board of directors will determine the specific ratio and timing of the reverse stock split.
• The company will file a certificate of amendment with the Secretary of State of Delaware to effect the reverse stock split.
• Stockholders will be notified of the effective date of the reverse stock split.

Key Dates

Keywords

reverse stock split, common stock, Nasdaq, listing compliance, stockholder approval, Conduit Pharmaceuticals, stock price, investor interest